|
|
Volumn 332, Issue 6029, 2011, Pages 525-
|
|
'Breakthrough' deal on flu strains has modest provisions
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
INFLUENZA VACCINE;
DEVELOPING WORLD;
INFLUENZA;
PUBLIC HEALTH;
VACCINE;
VIRUS;
WORLD HEALTH ORGANIZATION;
DEVELOPING COUNTRY;
DRUG COST;
HEALTH CARE ACCESS;
HUMAN;
INFECTION CONTROL;
INFLUENZA;
INFLUENZA A;
INFLUENZA A (H1N1);
INFLUENZA A (H5N1);
INFLUENZA VACCINATION;
INFLUENZA VIRUS A H1N1;
INFLUENZA VIRUS A H5N1;
INTERNATIONAL COOPERATION;
NONHUMAN;
PANDEMIC INFLUENZA;
PRIORITY JOURNAL;
SHORT SURVEY;
STRAIN IDENTIFICATION;
VACCINE PRODUCTION;
WORLD HEALTH ORGANIZATION;
DRUG INDUSTRY;
ISOLATION AND PURIFICATION;
NOTE;
ORTHOMYXOVIRUS;
PANDEMIC;
PATENT;
VIROLOGY;
GENEVA [SWITZERLAND];
SWITZERLAND;
ORTHOMYXOVIRIDAE;
DEVELOPING COUNTRIES;
DRUG INDUSTRY;
HUMANS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
INTELLECTUAL PROPERTY;
INTERNATIONAL COOPERATION;
ORTHOMYXOVIRIDAE;
PANDEMICS;
WORLD HEALTH ORGANIZATION;
|
|
EID: 79955543752
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.332.6029.525 Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|
